Clinical Trial Update: Mixed Antagonist of Serotonin for Claudication Optimal Therapy [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 study evaluating a mixed antagonist of serotonin for intermittent claudication, with no results detailed in the sn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication

Drugs mentioned

• Mixed Antagonist of Serotonin

Snippet

Sponsor: Sanofi | Conditions: Intermittent Claudication | Phase 2 | Status: COMPLETED